Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Proteinuria].

Jean-Pierre Fauvel1, Maurice Laville

  • 1Service de Néphrologie et Hypertension Artérielle, Hôpital Edouard-Herriot, Pavillon P, Lyon et EA 645 Université Claude-Bernard-Lyon-I, 69437 Lyon cedex 03, France. jean-pierre.fauvel@chu-lyon.fr

Nephrologie & Therapeutique
|August 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depressive symptoms in chronic kidney disease: the hidden role of uremic toxins.

BMJ mental health·2026
Same author

Anticholinergic Burden and Progression to Kidney Replacement Therapy.

Kidney international reports·2026
Same author

Hyperpolypharmacy in patients with chronic kidney disease and its impact on clinical outcomes.

Scientific reports·2026
Same author

CKD-M2 study: 2-year mortality prediction tool for advanced kidney disease.

BMC nephrology·2025
Same author

AI-BASED Tool to Estimate Sodium Intake in STAGE 3 to 5 CKD Patients-The UniverSel Study.

Nutrients·2025
Same author

A longitudinal analysis of haemoglobin levels and major cardiovascular events.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2025
Same journal

Nutritional monitoring in peritoneal dialysis: Biological and non-biological markers and dietary strategies

Nephrologie & therapeutique·2026
Same journal

Supporting patients and family members facing treatment choices in chronic kidney disease: What do professionals think of the decision aids used? - Professionals’ views on treatment decision support tools

Nephrologie & therapeutique·2026
Same journal

From Turing to ChatGPT: The origins and transformations of medical artificial intelligence

Nephrologie & therapeutique·2026
Same journal

Analysis of the predictive value of serum Cys-C and IL-6 levels for acute kidney injury in patients with acute respiratory distress syndrome.

Nephrologie & therapeutique·2026
Same journal

Navigating pain in chronic kidney disease: Overcoming inertia!

Nephrologie & therapeutique·2026
Same journal

Kidney health for all: caring for people, protecting the planet1.

Nephrologie & therapeutique·2026
See all related articles

Regular screening for proteinuria aids early kidney disease detection and treatment. Quantitative tests confirm dipstick results, guiding timely therapy to slow disease progression and improve outcomes.

Area of Science:

  • Nephrology
  • Clinical Chemistry

Context:

  • Health organizations recommend regular proteinuria screening for early kidney disease detection.
  • Proteinuria is a key indicator of kidney damage, as proteins typically do not pass through healthy kidney filters.
  • Dipstick tests for proteinuria require confirmation with quantitative measurements to assess persistence.

Purpose:

  • To highlight the importance of proteinuria screening in diagnosing and managing kidney disease.
  • To explain the role of proteinuria and other markers in assessing kidney damage and prognosis.
  • To emphasize the benefits of early detection and intervention in slowing kidney disease progression.

Summary:

  • Proteinuria, detected via dipstick and confirmed quantitatively, signals kidney damage.
  • Additional markers like urine sediment, kidney ultrasound, and glomerular filtration rate (GFR) aid in diagnosis and risk assessment.

Related Experiment Videos

  • Microalbuminuria is linked to poor cardiovascular prognosis, while high proteinuria levels (e.g., >3.0 g/d) in glomerular disease indicate significant kidney damage.

    • Impact:

    • Early detection of kidney disease through proteinuria screening allows for timely treatment, potentially slowing disease progression.
    • Accurate assessment of proteinuria and other kidney function markers aids in determining the type of chronic kidney disease and predicting prognosis.
    • Identifying microalbuminuria is crucial for managing associated cardiovascular risks in patients with diabetes and hypertension.